NewGenIvf (NIVF) EPS (Basic) (2024 - 2025)

NewGenIvf (NIVF) reported EPS (Basic) of $173.09 for Q3 2025, up 1158126.33% year-over-year from N/an in Q3 2024, and up 113507.56% quarter-over-quarter from -$0.15 in Q4 2024.

NewGenIvf (NIVF) EPS (Basic) (2024 - 2025) Analysis & Trends

NewGenIvf (NIVF) has 2 years of EPS (Basic) data on file, last reported at $173.09 in Q3 2025.

  • EPS (Basic) for Q3 2025 came in at $173.09, up 1158126.33% year-over-year; the trailing twelve-month figure through Sep 2025 was $172.92 (changed N/A YoY), and the FY2025 annual result was $214.73, up 104.87% from the prior year.
  • EPS (Basic) grew to $173.09 in Q3 2025 per NIVF's latest filing, from -$0.15 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $173.09 in Q3 2025 and troughed at -$0.15 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn 7.25
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 8.09
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn 2.93
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn 1.96
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn 1.73
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn 5.71
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 0.21
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 4.85
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn 0.51
10 NewGenIvf - - 524,025.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 173.09
Dec 31, 2024 -0.15
Sep 30, 2024 -0.01